Business Wire

October 5, 2009  

Minnow Medical Selected to Present at AdvaMed 2009 Conference on October 13

SAN DIEGO--(BUSINESS WIRE)--Minnow Medical, Inc., a developer of innovative products to treat artery disease, today announced that it was among the medical technology companies selected to deliver a company profile presentation to potential investors and partners at AdvaMed 2009. Minnow Medical’s President and Chief Executive Officer, Tom Steinke, will deliver the presentation on Tuesday, October 13^th, at 3:30 p.m. eastern.

“We are honored to be presenting at AdvaMed 2009, as the selection was made by a respected committee based on the quality and potential of our new treatment for peripheral artery disease,” said Mr. Steinke. “This conference is one of the most important industry forums, as it brings together leaders from business, technology, public policy and the investment community.”

Applications for the company profile presentations were evaluated by a committee of industry leaders and stakeholders; approximately 45 companies with the highest scores were offered the opportunity to present. AdvaMed 2009 is being held October 12-14 at the Walter E. Washington Convention Center in Washington, D.C.

About Minnow Medical, Inc.

Minnow Medical, Inc., headquartered in San Diego, California, is a development-stage company founded in 2003. Minnow Medical is establishing its first products in the treatment of peripheral artery disease. Minnow Medical’s extensive experience in cardiovascular biology, radiofrequency energy, and tissue biology, combined with scientific experience in atherosclerosis, has resulted in the development of an advanced technology in the treatment of artery disease.